246 related articles for article (PubMed ID: 36672315)
1. Radiomic Analysis Based on Magnetic Resonance Imaging for Predicting PD-L2 Expression in Hepatocellular Carcinoma.
Tao YY; Shi Y; Gong XQ; Li L; Li ZM; Yang L; Zhang XM
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672315
[TBL] [Abstract][Full Text] [Related]
2. Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma.
Gong XQ; Liu N; Tao YY; Li L; Li ZM; Yang L; Zhang XM
Sci Rep; 2023 May; 13(1):7710. PubMed ID: 37173350
[TBL] [Abstract][Full Text] [Related]
3. Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.
Dai H; Lu M; Huang B; Tang M; Pang T; Liao B; Cai H; Huang M; Zhou Y; Chen X; Ding H; Feng ST
Quant Imaging Med Surg; 2021 May; 11(5):1836-1853. PubMed ID: 33936969
[TBL] [Abstract][Full Text] [Related]
4. Radiomic Features of Multi-ROI and Multi-Phase MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma.
Yang Y; Fan W; Gu T; Yu L; Chen H; Lv Y; Liu H; Wang G; Zhang D
Front Oncol; 2021; 11():756216. PubMed ID: 34692547
[TBL] [Abstract][Full Text] [Related]
5. Development of a magnetic resonance imaging-derived radiomics model to predict microvascular invasion in patients with hepatocellular carcinoma.
Liu J; Cheng D; Liao Y; Luo C; Lei Q; Zhang X; Wang L; Wen Z; Gao M
Quant Imaging Med Surg; 2023 Jun; 13(6):3948-3961. PubMed ID: 37284095
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics.
Liu N; Wu Y; Tao Y; Zheng J; Huang X; Yang L; Zhang X
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001633
[TBL] [Abstract][Full Text] [Related]
7. DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma.
Zheng J; Du PZ; Yang C; Tao YY; Li L; Li ZM; Yang L
Abdom Radiol (NY); 2023 Nov; 48(11):3343-3352. PubMed ID: 37495746
[TBL] [Abstract][Full Text] [Related]
8. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
Fan Y; Yu Y; Wang X; Hu M; Hu C
BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
[TBL] [Abstract][Full Text] [Related]
9. Preoperative prediction of microvascular invasion (MVI) in hepatocellular carcinoma based on kupffer phase radiomics features of sonazoid contrast-enhanced ultrasound (SCEUS): A prospective study.
Dong Y; Zuo D; Qiu YJ; Cao JY; Wang HZ; Yu LY; Wang WP
Clin Hemorheol Microcirc; 2022; 81(1):97-107. PubMed ID: 35001883
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Evaluation of Gd-EOB-DTPA-Enhanced MRI Radiomics-Based Nomogram in Small Solitary Hepatocellular Carcinoma (≤3 cm) With Microvascular Invasion: A Two-Center Study.
Tian Y; Hua H; Peng Q; Zhang Z; Wang X; Han J; Ma W; Chen J
J Magn Reson Imaging; 2022 Nov; 56(5):1459-1472. PubMed ID: 35298849
[TBL] [Abstract][Full Text] [Related]
11. Radiomic analysis based on multi-phase magnetic resonance imaging to predict preoperatively microvascular invasion in hepatocellular carcinoma.
Li YM; Zhu YM; Gao LM; Han ZW; Chen XJ; Yan C; Ye RP; Cao DR
World J Gastroenterol; 2022 Jun; 28(24):2733-2747. PubMed ID: 35979164
[TBL] [Abstract][Full Text] [Related]
12. MRI-Based Radiomic Features Help Identify Lesions and Predict Histopathological Grade of Hepatocellular Carcinoma.
Brancato V; Garbino N; Salvatore M; Cavaliere C
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626241
[TBL] [Abstract][Full Text] [Related]
13. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
14. Computed Tomography Radiomics-Based Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
Yao W; Yang S; Ge Y; Fan W; Xiang L; Wan Y; Gu K; Zhao Y; Zha R; Bu J
Front Med (Lausanne); 2022; 9():819670. PubMed ID: 35402463
[TBL] [Abstract][Full Text] [Related]
15. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.
Feng ST; Jia Y; Liao B; Huang B; Zhou Q; Li X; Wei K; Chen L; Li B; Wang W; Chen S; He X; Wang H; Peng S; Chen ZB; Tang M; Chen Z; Hou Y; Peng Z; Kuang M
Eur Radiol; 2019 Sep; 29(9):4648-4659. PubMed ID: 30689032
[TBL] [Abstract][Full Text] [Related]
16. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.
Sun Y; Bai H; Xia W; Wang D; Zhou B; Zhao X; Yang G; Xu L; Zhang W; Liu P; Xu J; Meng S; Liu R; Gao X
J Magn Reson Imaging; 2020 Oct; 52(4):1083-1090. PubMed ID: 32233054
[TBL] [Abstract][Full Text] [Related]
17. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
18. Preoperative prediction of microvascular invasion in hepatocellular carcinoma: a radiomic nomogram based on MRI.
Li L; Su Q; Yang H
Clin Radiol; 2022 Apr; 77(4):e269-e279. PubMed ID: 34980458
[TBL] [Abstract][Full Text] [Related]
19. Comparison of MRI and CT for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma Based on a Non-Radiomics and Radiomics Method: Which Imaging Modality Is Better?
Meng XP; Wang YC; Zhou JY; Yu Q; Lu CQ; Xia C; Tang TY; Xu J; Sun K; Xiao W; Ju S
J Magn Reson Imaging; 2021 Aug; 54(2):526-536. PubMed ID: 33622022
[TBL] [Abstract][Full Text] [Related]
20. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
